This is a preview of subscription content, log in via an institution to check access.
References
Kirkfeldt RE, Johansen JB, Nielsen JC. Management of cardiac electronic device infections: challenges and outcomes. Arrhythm Electrophysiol Rev. 2016;5(3):183–7.
Tarakji KG, Wilkoff BL. Antibacterial envelope to prevent cardiac implantable device infection. Reply N Engl J Med. 2019;381(18):1783–4.
de Oliveira JC, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29–34.
Baman TS, et al. Risk factors for mortality in patients with cardiac device-related infection. Circ: Arrhythmia Electrophysiol. 2009;2(2):129–34.
Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.
Le KY, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678–85.
Levy S, Heyes B. Information systems that support effective clinical decision making. Nurs Manag (Harrow). 2012;19(7):20–2.
Nelson JL, et al. Prospective trial of real-time electronic surveillance to expedite early care of severe sepsis. Ann Emerg Med. 2011;57(5):500–4.
Jaimes F, et al. The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency room. Intensive Care Med. 2003;29(8):1368–71.
Narayanan N, et al. Effect of an electronic medical record alert for severe sepsis among ED patients. Am J Emerg Med. 2016;34(2):185–8.
Johansen JB, et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32(8):991–8.
Kirkfeldt RE, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.
Klug D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349–55.
Uslan DZ, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–75.
Nielsen JC, Gerdes JC, Varma N. Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J. 2015;36(37):2484–90.
Baddour LM, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Informed consent
Not applicable.
Conflict of interest
The authors declare no competing interests.
Data availability
The data from this study are not publicly available due to patient safety issues. The data are available from the corresponding author upon request.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Paz Rios, L.H., Minga, I., Gaznabi, S. et al. The impact of an electronic medical alert system for patients with cardiac implantable electronic devices and bacteremia. J Interv Card Electrophysiol 66, 525–529 (2023). https://doi.org/10.1007/s10840-022-01423-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01423-6